President Donald Trump has signed a new executive order aimed at reducing the cost of prescription drugs in the U.S., calling on pharmaceutical companies to match prices offered in other developed countries. The order, issued in May and reinforced with direct outreach to industry leaders on July 31, demands drugmakers lower their prices voluntarily within a set timeframe or face regulatory action. Trump\u2019s plan includes leveraging a \u201cmost-favored-nation\u201d approach, which would require companies to offer the U.S. the lowest price they charge internationally.<\/p>\n\n\n\n
Seventeen pharmaceutical companies, including major players like Pfizer, Eli Lilly, and AstraZeneca, received letters from the Trump administration giving them until September 29 to commit to price reductions. If they fail to comply, the administration has signaled it may pursue measures such as drug importation or pricing penalties. The initiative currently focuses on Medicaid and newly approved medications, but broader pricing regulations could be implemented if companies don\u2019t cooperate.<\/p>\n\n\n\n
The policy has sparked mixed reactions. Supporters argue it could finally bring relief to millions of Americans burdened by high drug costs, while critics warn it could lead to legal challenges, disrupt drug availability, or reduce innovation in the sector. Some experts note that meaningful reform may ultimately require congressional action, as executive orders alone may not withstand legal scrutiny. Still, advocacy groups like AARP have expressed cautious optimism, seeing it as a potential step toward more affordable healthcare.<\/p>\n","protected":false},"excerpt":{"rendered":"
President Donald Trump has signed a new executive order aimed at reducing the cost of prescription drugs in the U.S., calling on pharmaceutical companies to match prices offered in other developed countries.<\/p>\n","protected":false},"author":1,"featured_media":2681,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-2680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"acf":[],"rttpg_featured_image_url":{"full":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma.jpg",1200,800,false],"landscape":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma.jpg",1200,800,false],"portraits":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma.jpg",1200,800,false],"thumbnail":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-150x150.jpg",150,150,true],"medium":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-300x200.jpg",300,200,true],"large":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-1024x683.jpg",640,427,true],"1536x1536":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma.jpg",1200,800,false],"2048x2048":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma.jpg",1200,800,false],"digital-newspaper-featured":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-1020x700.jpg",1020,700,true],"digital-newspaper-list":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-600x400.jpg",600,400,true],"digital-newspaper-thumb":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-300x200.jpg",300,200,true],"digital-newspaper-small":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-150x95.jpg",150,95,true],"digital-newspaper-grid":["https:\/\/theamshift.com\/wp-content\/uploads\/2025\/08\/pharma-400x250.jpg",400,250,true]},"rttpg_author":{"display_name":"admin","author_link":"https:\/\/theamshift.com\/?author=1"},"rttpg_comment":0,"rttpg_category":"Politics<\/a>","rttpg_excerpt":"President Donald Trump has signed a new executive order aimed at reducing the cost of prescription drugs in the U.S., calling on pharmaceutical companies to match prices offered in other developed countries.","_links":{"self":[{"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/posts\/2680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theamshift.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2680"}],"version-history":[{"count":1,"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/posts\/2680\/revisions"}],"predecessor-version":[{"id":2682,"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/posts\/2680\/revisions\/2682"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theamshift.com\/index.php?rest_route=\/wp\/v2\/media\/2681"}],"wp:attachment":[{"href":"https:\/\/theamshift.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theamshift.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theamshift.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}